loading

Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten

Capital One Financial Brokers Boost Earnings Estimates for Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

pulisher
MarketBeat

Ionis (IONS), Biogen Down on Ending Development of ALS Drug

pulisher
Zacks Investment Research

Northland maintains $9 target on Heron Therapeutics By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Heron Therapeutics (NASDAQ:HRTX) Receives Buy Rating from Needham & Company LLC - MarketBeat

pulisher
MarketBeat

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Up 7.3% in April - MarketBeat

pulisher
MarketBeat

Heron Therapeutics Inc [HRTX] stock for 27250 USD was acquired by Forbes William P – Knox Daily - Knox Daily

pulisher
Knox Daily

Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo News UK

pulisher
Yahoo News UK

Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options - Yahoo Singapore News

pulisher
Yahoo Singapore News

Insider's View: Deciphering Heron Therapeutics Inc (HRTX)'s Financial Health Through Ratios – DWinneX - The Dwinnex

pulisher
The Dwinnex

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

pulisher
Zacks Investment Research

Check out these key findings about Heron Therapeutics Inc (HRTX) – Sete News - SETE News

pulisher
SETE News

How Much Upside is Left in Heron Therapeutics (HRTX)? Wall Street Analysts Think 91% - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Heron Therapeutics' (HRTX) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

pulisher
Defense World

Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Monaco Asset Management SAM Raises Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

pulisher
MarketBeat

Q2 2024 Earnings Forecast for Heron Therapeutics, Inc. (NASDAQ:HRTX) Issued By Northland Capmk - Defense World

pulisher
Defense World

Q2 2024 EPS Estimates for Heron Therapeutics, Inc. (NASDAQ:HRTX) Increased by Analyst - MarketBeat

pulisher
MarketBeat

Los Angeles Capital Management LLC Boosts Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

pulisher
Defense World

Heron Therapeutics: 2Q Earnings Snapshot - Yahoo News UK

pulisher
Yahoo News UK

Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo News UK

pulisher
Yahoo News UK

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance

pulisher
Yahoo Finance

Biotech Finds Mid-Week Success Following Q4 Earnings Release - The Globe and Mail

pulisher
The Globe and Mail

Biotech Finds Mid-Week Success Following Q4 Earnings Release - The Globe and Mail

pulisher
The Globe and Mail

Heron Therapeutics' (HRTX) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

pulisher
MarketBeat

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

Heron Therapeutics First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

pulisher
Yahoo Finance

Heron Therapeutics: Q1 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

Heron Therapeutics' (HRTX) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

pulisher
MarketBeat

Earnings call: Heron Therapeutics reports revenue growth in Q1 2024 - Investing.com South Africa

pulisher
Investing.com South Africa

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates - Investing.com South Africa

pulisher
Investing.com South Africa

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates - Yahoo Finance

pulisher
Yahoo Finance

Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

pulisher
Yahoo Finance

Heron Therapeutics Insider Confidence Rewarded, Stock Hits US$428m Market Cap - Simply Wall St

pulisher
Simply Wall St

Heron Therapeutics: Q1 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

Heron Therapeutics (HRTX) Scheduled to Post Earnings on Tuesday - Defense World

pulisher
Defense World

Are Heron Therapeutics Inc'shares a good deal? – US Post News - US Post News

pulisher
US Post News

Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline

pulisher
Zacks Investment Research

Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know

pulisher
Zacks Investment Research

Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance

pulisher
Yahoo Finance

Trading Day Review: Heron Therapeutics Inc (HRTX) Loses Momentum, Closing at 2.45 – DWinneX - The Dwinnex

pulisher
The Dwinnex

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook - Yahoo Finance

pulisher
Yahoo Finance

Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 - Yahoo Finance

pulisher
Yahoo Finance

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tu - Benzinga

pulisher
Benzinga

Heron Therapeutics: Zynrelef Eases Shareholder Pain (HRTX) - Seeking Alpha

pulisher
Seeking Alpha

Heron Therapeutics Inc (HRTX) did well last session? – US Post News - US Post News

pulisher
US Post News

Heron Therapeutics (NASDAQ:HRTX) adds US$56m to market cap in the past 7 days, though investors from five years ago are still down 87% - Simply Wall St

pulisher
Simply Wall St

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City - PR Newswire

pulisher
PR Newswire

HRTX Stock Quote Price and Forecast - CNN

pulisher
CNN

Heron Therapeutics Announces New Principal Accounting Officer - TipRanks.com - TipRanks

pulisher
TipRanks
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Kapitalisierung:     |  Volumen (24h):